The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of a novel DNA vaccine in patients (pts) with smoldering Waldenstrom macroglobulinemia (sWM).
 
Sheeba K. Thomas
Research Funding - Acerta Pharma; Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene
 
Soungchul Cha
No Relationships to Disclose
 
Sapna R Parshottam
No Relationships to Disclose
 
Sheetal S Rao
No Relationships to Disclose
 
Jasper B. Olsem
No Relationships to Disclose
 
Brandon N. Crumpton
No Relationships to Disclose
 
Lei Feng
No Relationships to Disclose
 
Hans Chulhee Lee
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Celgene; Pimera; Takeda
Research Funding - Amgen; Celgene; Daiichi Sankyo; Janssen; Prothena; Takeda
 
Elisabet Esteve Manasanch
Honoraria - Celgene; Novartis; Sanofi; Takeda
Research Funding - JW Pharmaceutical; Merck; Quest Diagnostics; Sanofi
 
Donna M. Weber
No Relationships to Disclose
 
Krina K. Patel
Research Funding - Abbvie; Celgene; Poseida Therapeutics; Takeda
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Takeda
Research Funding - Amgen; BioTheryX; Spectrum Pharmaceuticals
 
Sattva Swarup Neelapu
Honoraria - Bio Ascend; Dava Oncology; Medscape; Physicans' Education Resource
Consulting or Advisory Role - Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics; poseida therapeutics; Unum Therapeutics
Travel, Accommodations, Expenses - Celgene; Chugai Pharma; Dava Oncology; Kite/Gilead; Medscape; Merck; Novartis; Pfizer; Physicans' Education Resource; Precision Biosciences; Unum Therapeutics
 
Larry W. Kwak
Stock and Other Ownership Interests - InnoLife; Pepromene; XEME BioPharma
Honoraria - Teva
Consulting or Advisory Role - Enzychem Lifesciences; InnoLife; Kolon; Pepromene; Sellas Life Sciences; XEME BioPharma
Research Funding - InnoLife; Pepromene
Travel, Accommodations, Expenses - Celltrion